About Katie Stenstrom
Katie is a corporate senior associate in our global transactions group.
Her areas of practice include complex public and private M&A, corporate restructurings, as well as general UK listed company advisory matters for international corporate and FTSE clients.
AstraZeneca on its $39bn acquisition of NASDAQ-listed Alexion, Inc., the largest US acquisition of 2020
AstraZeneca on its £3.5bn equity placing via an accelerated book build process, the largest undocumented equity raise in Europe ever
Rentokil Initial on its $6.7bn acquisition of Terminix.
Tullow Oil on the sale of its entire stake in the Lake Albert Development Project in Uganda to TotalEnergies for US$575 million in cash plus post first oil contingent payments.
UKGI in relation to HMT’s trading plan and sale of shares in NatWest Group.
SSE on the demerger of its retail business and sale to Ovo and the disposal of its 50% interest in the Multifuel energy-from-waste JV.
Merck on the sale of its consumer healthcare business to P&G.
King’s College London (double honours degree)
University of Paris 1 Panthéon – Sorbonne
BPP University Law School (Legal Practice Course)